Industries > Pharma > Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

PUBLISHED: 09 January 2013
PAGES: 157
PRODUCT CODE:
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

A myriad of pharmaceutical and diagnostic companies are now entering the highly attractive market of companion diagnostics, many of them entering into collaborations for developing a combination product. Apart from the well-known pharmaceutical and diagnostic companies, some small, niche-companies are also focusing on companion diagnostic development. At present, competition is largely dependent on the ability to collaborate with biotechnology and pharmaceutical companies to develop and commercialise these tests for their therapeutic drugs and drug candidates. The number of partnerships between the two industries will keep expanding as most pharmaceutical companies do not have an in-house diagnostic capability for either the development of a companion diagnostic or the commercialisation of the test once the drug is approved.

Top Companion Diagnostic Companies: Competitive Analysis 2013-2023 analyses the top 12 companies involved in the companion diagnostics market. This report also provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis. There are 125 tables and figures included. The result is a comprehensive market, and industry-centred study, with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global companion diagnostics market will reach $19.3bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

• 137 pages of comprehensive analysis
• 1 Exclusive Visiongain interviews with experts from-
– Myriad Genetics
• 125 tables, charts, and graphs
• Companion diagnostic market forecast between 2012-2023
• 2 companion diagnostic submarket forecasts from 2012-2023
– Theranostics
– Other companion diagnostics
• A SWOT analysis
• Several leading companies identified and 12 profiled –
Roche, Dako, QIAGEN, Abbott, Life Technologies, LabCorp, Genomic Health, MDxHealth, bioMerieux, Johnson and Johnson, Siemens and Myriad Genetics

You can order this report today

Gain an understanding of the overall companion diagnostics market and the leading companies operating in this market by ordering Top Companion Diagnostic Companies: Competitive Analysis 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Top Companion Diagnostic Companies: Competitive Analysis 2013-2023


Download sample pages

Complete the form below to download your free sample pages for Top Companion Diagnostic Companies: Competitive Analysis 2013-2023


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories